Januvia Tablet 50 mg (Sitagliptin Phosphate Hydrate)

Adult dose

This medication is administered once daily at a dose of 100 mg, either as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. It can be taken regardless of meals. Adjustment of dosage is necessary for patients with renal impairment. For patients with moderate renal impairment (eGFR 30-45 mL/min/1.73 m²), a dose of 50 mg is administered once daily. For patients with severe renal impairment or those requiring hemodialysis or peritoneal dialysis (eGFR

This medication may cause severe allergic reactions. If symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and consult a doctor. During treatment with this medication, symptoms of pancreatitis, an inflammation of the pancreas, may appear. If abdominal pain, vomiting, or persistent abdominal pain occurs, promptly inform a healthcare professional. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication, and those with hypersensitivity to this medication should also avoid it. Patients with impaired kidney function should have their dosage adjusted, so those with renal diseases should discuss appropriate dosing with their doctor. This drug can be used alone or in combination with other diabetes treatments, but when taken with insulin or sulfonylureas, the risk of hypoglycemia may increase, so regular monitoring of blood sugar is necessary. While taking this medication, symptoms such as headache, nasopharyngitis, upper respiratory tract infection, diarrhea, nausea, etc., may occur; if symptoms worsen, it is advisable to consult a healthcare professional. Severe joint pain or skin diseases such as bullous pemphigoid may develop; if these symptoms appear, immediately inform a doctor and stop taking the medication. This medication is not recommended for pregnant women or nursing mothers, so if there is a plan for pregnancy or if you are pregnant, you should definitely consult a doctor. Safety and efficacy have not been sufficiently confirmed in children, particularly those under 18 years old, so its use should be avoided. Elderly patients may have decreased kidney function, so it is necessary to have regular kidney function tests before and during the use of this medication. In cases of overdose, standard emergency measures should be taken, and if necessary, dialysis may be performed to remove the medication; thus, if the medication is taken incorrectly, contact a healthcare facility immediately.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing (including anaphylaxis), cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in oral/eye mucosa (including Stevens-Johnson syndrome), severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, breathing abnormalities accompanied by cough+fever, respiratory problems, yellowing of the skin or eyes (jaundice)

Mild side effects

• Upper respiratory tract infection
• nasopharyngitis
• headache
• abdominal pain
• nausea
• diarrhea
• constipation
• vomiting
• myalgia
• limb pain

This medication should be stored in a tightly sealed container to prevent air from entering and kept at room temperature between 1°C and 25°C. Proper storage can help maintain the medication's effectiveness for a prolonged period.

Appearance

A round, biconvex film-coated tablet that is light beige in color and has '112' engraved on one side.

Package unit

28 tablets (14 tablets/PTP x 2)